Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
Open Access
- 14 December 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 21 (2) , 353-355
- https://doi.org/10.1038/sj.leu.2404485
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 2003
- Tolerance, DCs and tryptophan: much ado about IDOTrends in Immunology, 2003
- Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-DioxygenaseScience, 2002
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseThe Journal of Experimental Medicine, 2002
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999